2a4g

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
(New page: 200px<br /><applet load="2a4g" size="350" color="white" frame="true" align="right" spinBox="true" caption="2a4g, resolution 2.50&Aring;" /> '''Hepatitis C Protease...)
Line 4: Line 4:
==Overview==
==Overview==
-
We have discovered that introduction of appropriate amino acid derivatives, at P'2 position improved the binding potency of P3-capped alpha-ketoamide, inhibitors of HCV NS3 serine protease. X-ray crystal structure of one of, the inhibitors (43) bound to the protease revealed the importance of the, P'2 moiety.
+
We have discovered that introduction of appropriate amino acid derivatives at P'2 position improved the binding potency of P3-capped alpha-ketoamide inhibitors of HCV NS3 serine protease. X-ray crystal structure of one of the inhibitors (43) bound to the protease revealed the importance of the P'2 moiety.
==About this Structure==
==About this Structure==
Line 15: Line 15:
[[Category: Arasappan, A.]]
[[Category: Arasappan, A.]]
[[Category: Bennett, F.]]
[[Category: Bennett, F.]]
-
[[Category: Bogen, S.L.]]
+
[[Category: Bogen, S L.]]
[[Category: Butkiewicz, N.]]
[[Category: Butkiewicz, N.]]
-
[[Category: Chan, T.Y.]]
+
[[Category: Chan, T Y.]]
[[Category: Chen, K.]]
[[Category: Chen, K.]]
-
[[Category: Ganguly, A.K.]]
+
[[Category: Ganguly, A K.]]
[[Category: Girijavallabhan, V.]]
[[Category: Girijavallabhan, V.]]
[[Category: Gu, H.]]
[[Category: Gu, H.]]
Line 28: Line 28:
[[Category: Levy, O.]]
[[Category: Levy, O.]]
[[Category: Lim-Wilby, M.]]
[[Category: Lim-Wilby, M.]]
-
[[Category: Liu, Y.T.]]
+
[[Category: Liu, Y T.]]
-
[[Category: Lovey, R.G.]]
+
[[Category: Lovey, R G.]]
[[Category: Malcolm, B.]]
[[Category: Malcolm, B.]]
[[Category: Marten, B.]]
[[Category: Marten, B.]]
[[Category: Mckittrick, B.]]
[[Category: Mckittrick, B.]]
-
[[Category: Njoroge, F.G.]]
+
[[Category: Njoroge, F G.]]
[[Category: Parekh, T.]]
[[Category: Parekh, T.]]
[[Category: Pichardo, J.]]
[[Category: Pichardo, J.]]
-
[[Category: Pike, R.E.]]
+
[[Category: Pike, R E.]]
[[Category: Pinto, P.]]
[[Category: Pinto, P.]]
-
[[Category: Prongay, A.J.]]
+
[[Category: Prongay, A J.]]
-
[[Category: Saksena, A.K.]]
+
[[Category: Saksena, A K.]]
[[Category: Santhanam, B.]]
[[Category: Santhanam, B.]]
[[Category: Tamura, S.]]
[[Category: Tamura, S.]]
Line 53: Line 53:
[[Category: virus/viral protein]]
[[Category: virus/viral protein]]
-
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Tue Jan 29 17:54:13 2008''
+
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Thu Feb 21 16:23:30 2008''

Revision as of 14:23, 21 February 2008


2a4g, resolution 2.50Å

Drag the structure with the mouse to rotate

Hepatitis C Protease NS3-4A serine protease with Ketoamide Inhibitor SCH225724 Bound

Overview

We have discovered that introduction of appropriate amino acid derivatives at P'2 position improved the binding potency of P3-capped alpha-ketoamide inhibitors of HCV NS3 serine protease. X-ray crystal structure of one of the inhibitors (43) bound to the protease revealed the importance of the P'2 moiety.

About this Structure

2A4G is a Protein complex structure of sequences from Hepatitis c virus with and as ligands. Full crystallographic information is available from OCA.

Reference

Hepatitis C virus NS3-4A serine protease inhibitors: SAR of P'2 moiety with improved potency., Arasappan A, Njoroge FG, Chan TY, Bennett F, Bogen SL, Chen K, Gu H, Hong L, Jao E, Liu YT, Lovey RG, Parekh T, Pike RE, Pinto P, Santhanam B, Venkatraman S, Vaccaro H, Wang H, Yang X, Zhu Z, Mckittrick B, Saksena AK, Girijavallabhan V, Pichardo J, Butkiewicz N, Ingram R, Malcolm B, Prongay A, Yao N, Marten B, Madison V, Kemp S, Levy O, Lim-Wilby M, Tamura S, Ganguly AK, Bioorg Med Chem Lett. 2005 Oct 1;15(19):4180-4. PMID:16087332

Page seeded by OCA on Thu Feb 21 16:23:30 2008

Proteopedia Page Contributors and Editors (what is this?)

OCA

Personal tools